People · Operator
Named in public records as an officer, director or promoter · active 2009–2013 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vertos Medical Inc | — | Healthtech | Series C | $177.3M | $514.0M | 2009 |
Daniel M. Pelak at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel M. Pelak on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Ryan | 1 | 17 |
| Andrew Firlik | 1 | 14 |
| Bruce Feuchter | 1 | 12 |
| Myles Greenberg | 1 | 6 |
| Ittai Harel | 1 | 6 |
| Daniel Pelak | 1 | 5 |
| Daniel M. Watkins | 1 | 5 |
| Daniel Watkins | 1 | 4 |
| Hugo Harrod | 1 | 3 |
| Robert Kuhling | 1 | 3 |
| James Corbett | 1 | 3 |
| Harry M Ross | 1 | 2 |
| John M. Ryan | 1 | 2 |
| Michael Boggs | 1 | 2 |
| Rebecca Colbert | 1 | 2 |
| Andrew M Firlik | 1 | 2 |
| Eric Wichems | 1 | 1 |
| Mike Boggs | 1 | 1 |
| Zachary Scott | 1 | 1 |
| John F. Ryan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.